Updated: Jul 11, 2007
Peripheral vascular injuries may occur through multiple mechanisms. These injuries may be difficult to detect; however, they may also cause serious morbidity and on occasion be life-threatening. Therefore, having a rational approach to the diagnosis and treatment of such patients to prevent a potentially catastrophic outcome is important.
Penetrating trauma to the extremities may result in peripheral vascular injury. Stab and gunshot wounds can both result in partial or complete transection of vascular structures via direct contact. In addition, gunshot wounds may indirectly cause vascular trauma. As a consequence of the cavity left behind by a bullet, the tissue recoils back to fill the space, and this motion may cause injury to adjacent vascular structures. The amount of indirect damage done relies on the velocity and mass of the bullet.
Blunt forces may also result in vascular injury. This may occur via shearing forces transmitted to the vessel or direct crushing of the vessel. These injuries may be associated with obvious mechanisms, such as motor vehicle accidents or severe crush injuries, but they should also be suspected in cases of bites from large dogs, electrical injuries, and other instances where large amounts of force may be applied to the tissue surrounding a vascular structure.
Searching for neurologic damage as well as fractures is important in patients with peripheral vascular injuries. Peripheral nerves are usually closely associated with vascular structures in the limbs, and the large forces often involved in vascular injuries may result in fractures.
Peripheral vascular injuries comprise approximately 3% of major injuries. Most are caused by penetrating trauma, but blunt trauma and iatrogenic injuries are also important mechanisms.
Penetrating peripheral vascular injuries secondary to gunshots or stab wounds are more common in males than in females.
Traumatic injury disproportionately affects younger persons and is the leading cause of death in those aged 1-44 years.
Always assess ABCs first. During the primary survey, any extremity hemorrhage should be addressed. The patient can then be examined for potential vascular injury. A thorough examination of all injured extremities should be performed. Particular attention should be paid to assessing pulses, capillary refill, deformities, and neurologic function. Two-point discrimination and strength testing should be included in the neurologic examination.
Below are clusters of physical examination findings and historical features that aid in the diagnostic and therapeutic approach to patients in whom vascular injury is considered.
Most injuries are secondary to acts of violence involving gunshot or stab wounds. Vascular injuries usually are caused by penetrating trauma from knives, bullets, and glass. Motor vehicle accidents, heavy machinery-related injuries, and falls cause a small proportion of blunt vascular injuries secondary to decelerating or crushing forces.
Penetrating injuries cause damage to vascular structures by direct injury (eg, secondary to stab or low-velocity missile wounds) and/or high-velocity injury (eg, cavitation effect by passage of a high-velocity missile through tissue with transfer of large amounts of kinetic energy). Destructive power increases proportionately with missile velocity and mass. These types of injuries can cause severe damage, even in the absence of direct vascular trauma.
| Abdominal Trauma, Blunt | Initial Evaluation of the Trauma Patient |
| Dislocations, Elbow | Shock, Hemorrhagic |
| Fractures, Femur | |
| Fractures, Knee | |
| Fractures, Tibia and Fibula |
Prompt consultation with the trauma team is routine at most major urban trauma centers. If isolated peripheral vascular injury is present, consult the vascular surgeon as soon as the patient stabilizes to reduce ischemia time.
The goal of therapy is to control pain and infections.
Pain control is essential to quality patient care. It ensures patient comfort, promotes pulmonary toilet, and aids physical therapy regimens. Most analgesics have sedating properties that benefit patients with traumatic injuries.
Use of pain medications in trauma victims is a difficult issue. Narcotics have several drawbacks, including exacerbating hypotension in hemorrhaging patients and mental status changes in patients with head injuries. These agents also may mask pain caused by subtle injuries. Nevertheless, in cases of isolated extremity trauma in stable patients, use pain medications. Use IV administration for more precise titration.
Potent narcotic analgesic with much shorter half-life than morphine sulfate. DOC for conscious sedation analgesia. Ideal for short-term (30-60 min) analgesic action during anesthesia and immediate postoperative period. Excellent choice for short-term pain management and sedation; easy to titrate. Easily and quickly reversed by naloxone. After initial dose, do not titrate subsequent doses more frequently than q3-6h. When using transdermal dosage form, most patients are controlled with 72-h dosing intervals, although some patients require 48-h dosing intervals.
Emergency: 0.5-2 mcg/kg/dose IV/IM
Analgesia: 0.5-1 mcg/kg/dose IM/IV q30-60min
Transdermal: Apply a 25-mcg/h system q48-72h
<2 years: 2-3 mcg/kg/dose IV/IM q30-60min
2-12 years: 1-2 mcg/kg/dose IV/IM q60min
>12 years: Administer as in adults
Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants may potentiate adverse effects when coadministered
Documented hypersensitivity; hypotension or potentially compromised airway in which it would be difficult to establish rapid airway control
C - Safety for use during pregnancy has not been established.
Caution in hypotension, respiratory depression, constipation, nausea, emesis, and urinary retention; an idiosyncratic reaction (chest wall rigidity syndrome) may require neuromuscular blockade to increase ventilation
DOC for narcotic analgesia due to reliable and predictable effects, safety profile, and ease of reversibility with naloxone; IV administration may be dosed in a number of ways and commonly is titrated until desired effect is obtained.
Starting dose: 0.1 mg/kg IV/IM/SC
Maintenance dose: 5-20 mg/70 kg IV/IM/SC q2-4h
Relatively hypovolemic patients: Start with 2 mg IV/IM/SC and reassess hemodynamic effects of dose
Neonates: 0.05-0.2 mg/kg dose IV/IM/SC prn
Children: 0.1-0.2 mg/kg dose IV/IM/SC q2-4h prn
Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants, MAOIs, and other CNS depressants may potentiate adverse effects of morphine when coadministered
Documented hypersensitivity; hypotension; potentially compromised airway in which establishing rapid airway control would be difficult
C - Safety for use during pregnancy has not been established.
Avoid in hypotension, respiratory depression, nausea, emesis, constipation, and urinary retention; caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate
Antibiotics should be used in all high-risk wounds. These include contaminated and devitalized wounds; patients with diabetes, HIV, or other immunocompromising disorder; and wounds caused by animal or human bites. Patients with underlying fractures should be treated with antibiotics in a similar fashion as anyone with an open fracture.
First-generation semisynthetic cephalosporin that arrests bacterial cell wall synthesis, inhibiting bacterial growth. Primarily active against skin flora, including Staphylococcus aureus. Typically used alone for skin and skin-structure coverage. IV and IM dosing regimens are similar.
250 mg to 2 g IV/IM q6-12h, depending on severity of infection; not to exceed 12 g/d
25-100 mg/kg/d IV/IM divided q6-8h, depending on severity of infection; not to exceed 6 g/d
Probenecid decreases renal clearance and prolongs effects; concurrent use with aminoglycosides may increase renal toxicity; administration may yield false-positive urine dip for glucose
Documented hypersensitivity
B - Usually safe but benefits must outweigh the risks.
Adjust dose in renal impairment; prolonged use of antibiotics is associated with superinfections and promotion of nonsusceptible organisms; complications usually are reversible
Tetanus immunization is indicated when 10 years have passed since last booster shot. If immunization status is unclear, tetanus immune globulin is required.
Used to induce active immunity against tetanus in selected patients. The immunizing agents of choice for most adults and children >7 y are tetanus and diphtheria toxoids. Necessary to administer booster doses to maintain tetanus immunity throughout life.
Pregnant patients should receive only tetanus toxoid not a diphtheria antigen-containing product.
In children and adults, may administer into deltoid or midlateral thigh muscles. In infants, preferred site of administration is the mid thigh laterally.
Primary immunization: 0.5 mL IM; administer 2 injections 4-8 wk apart and a third dose 6-12 mo after second injection
Booster dose: 0.5 mL IM q10y
Administer as in adults
Patients receiving immunosuppressants, including corticosteroids or radiation therapy, may remain susceptible despite immunization because of poor immune response; cimetidine may enhance or augment delayed-hypersensitivity responses to skin-test antigens; avoid concurrent use of systemic chloramphenicol, since it may impair amnestic response to tetanus toxoid; concurrent use of tetanus immunoglobulin may delay development of active immunity by several days; this interaction is clinically insignificant and does not preclude concurrent use
Documented hypersensitivity; history of any type of neurologic symptoms or signs following administration of this product; FDA recommends that elective tetanus immunization be deferred during any outbreak of poliomyelitis because tetanus toxoid injections are an important cause of provocative poliomyelitis
C - Safety for use during pregnancy has not been established.
Never use to treat actual tetanus infections or for immediate prophylaxis of unimmunized individuals; instead use tetanus antitoxin, preferably human tetanus immunoglobulin; diminished antibody response to active immunization may be seen in patients receiving immunosuppressive therapy; it is better to defer primary diphtheria immunization until immunosuppressive therapy is discontinued; routinely immunize symptomatic and asymptomatic persons who are infected with HIV
Used for passive immunization of patients with a wound that may be contaminated with tetanus spores.
250-500 U IM in extremity opposite to tetanus toxoid lesion
Administer as in adults
None reported
Because antibodies in globulin preparation may interfere with immune response to vaccination, do not administer within 3 mo of live-virus immunoglobulin administration; may be necessary to revaccinate patients who received immunoglobulin shortly after live-virus vaccination
C - Safety for use during pregnancy has not been established.
Patients with isolated IgA deficiency may develop antibodies to IgA and may have anaphylactic reactions to subsequent administration of blood products that contain IgA; do not perform skin testing because intradermal injection of concentrated gamma-globulin may cause a localized area of inflammation and can be misinterpreted as a positive allergic reaction rather than a localized chemical tissue irritation; medication mistakenly may be withheld from a nonallergic patient; true allergic responses to human gamma-globulin administered in the prescribed IM manner are extremely rare; do not mix with other medications, as they are usually incompatible
Busquets AR, Acosta JA, Colon E, Alejandro KV, Rodriguez P. Helical computed tomographic angiography for the diagnosis of traumatic arterial injuries of the extremities. J Trauma. Mar 2004;56(3):635-28. [Medline].
Gonzalez RP and Falimirski ME. The utility of physical examination in proximity penetrating extremity trauma. Am Surg. Aug 1999;65(8):784-9. [Medline].
Prêtre R, Bruschweiler I, Rossier J, Chilcott M, Bednarkiewicz M, Kürsteiner K, et al. Lower limb trauma with injury to the popliteal vessels. J Trauma. Apr 1996;40(4):595-601. [Medline].
Schwartz MR, Weaver FA, Bauer M, Siegel A, Yellin AE. Refining the indications for arteriography in penetrating extremity trauma: a prospective analysis. J Vasc Surg. Jan 1993;17(1):116-22; discussion 122-4. [Medline].
Bynoe RP, MIles WS, Bell RM, et al. Noninvasive diagnosis of vascular trauma by duplex ultrasonography. J Vasc Surg. Sep 1991;14(3):346-52. [Medline].
Kaplan LJ, Kellum JA. Initial pH, base deficit, lactate, anion gap, strong ion difference, and strong ion gap predict outcome from major vascular injury. Crit Care Med. May 2004;32(5):1120-4. [Medline].
American College of Emergency Physicians: Clinical policy for the initial approach to patients presenting with penetrating extremity trauma. Ann Emerg Med. May 1999;33(5):612-36. [Medline].
Asensio JA, Kuncir EJ, Garcia-Nunez LM, Petrone P. Femoral vessel injuries: analysis of factors predictive of outcomes. J Am Coll Surg. Oct 2006;203(4):512-20. Epub 2006 Aug 23. [Medline].
Dennis J, Frykberg E, Henry V, Huffman S, Menawat S. Validation of nonoperative management of occult vascular injuries and accuracy of physical examination alone in penetrating extremity trauma:5- to 10-year follow-up. J Trauma. Feb 1998;44(2):243-52; discussion 242-3. [Medline].
Gahtan V, Bramson RT, Norman J. The role of emergent arteriography in penetrating limb trauma. Am Surg. Feb 1994;60(2):123-7. [Medline].
Ianaba K, Potzman J, Munera F, et al. Multi-slice CT angiography for arterial evaluation in the injured lower extremity. J Trauma. Mar 2006;60(3):502-7; discussion 506-7. [Medline].
Itani KM, Rothenberg SS, Brandt ML, Burch JM, Mattox KL, Harberg FJ, et al. Emergency center arteriography in the evaluation of suspected peripheral vascular injuries in children. J Pediatr Surg. May 1993;28(5):677-80. [Medline].
Johansen K, Lynch K, Paun M, Copass M. Non-invasive vascular tests reliably exclude occult arterial trauma in injured extremities. J Trauma. Apr 1991;31(4):515-9; discussion 519-22. [Medline].
Knudson MM, Lewis FR, Atkinson K, Neuhaus A. The role of duplex ultrasound arterial imaging in patients with penetrating extremity trauma. Arch Surg. Sep 1993;128(9):1033-7; discussion 1037-8. [Medline].
Levy BA, Zlowodzki MP, Graves M, Cole PA. Screening for extremity arterial injury with the arterial pressure index. Am J Emerg Med. Sep 2005;23(5):689-95. [Medline].
Lynch K, Johansen K. Can Doppler pressure measurement replace "exclusion" arteriography in the diagnosis of occult extremity arterial trauma?. Ann Surg. Dec 1991;214(6):737-41. [Medline].
Miranda FE, Dennis JW, Veldenz HC, Dovgan PS, Frykberg ER. Confirmation of the safety and accuracy of physical examination in the evaluation of knee dislocation for injury of the popliteal artery: a prospective study. J Trauma. Feb 2002;52(2):247-51; discussion 251-2. [Medline].
Modrall JG, Weaver FA, Yellin AE. Diagnosis and management of penetrating vascular trauma and the injured extremity. Emerg Med Clin North Am. Feb 1998;16(1):129-44. [Medline].
Moniz MP, Ombrellaro MP, Stevens SL, Freeman MB, Diamond DL, Goldman MH. Concomitant orthopedic and vascular injuries as predictors for limb loss in blunt lower extremity trauma. Am Surg. Jan 1997;63(1):24-8. [Medline].
Mullenix PS, Steele SR, Andersen CA, Starnes BW, Salim A, Martin MJ. Limb salvage and outcomes among patients with popliteal vascular injury: an analysis of the national trauma data bank. J Vasc Surg. Jul 2006;44(1):94-100. [Medline].
Nassoura ZE, Ivatury RR, Simon RJ, Jabbour N, Vinzons A, Stahl W. A reassessment of Doppler pressure indices in the detection of arterial lesions in proximity penetrating injuries of extremities: a prospective study. Am J Emer Med. Mar 1996;14(2):151-6. [Medline].
Newton EJ. Peripheral vascular injury. In: Marx JA, Hockberger RS, Walls RM, et al. Marx:Rosen's Emergency Medicine:Concepts and Clinical Practice. 6th ed. Philadelphia, PA: Mosby Iinc; 2006:536-547.
Poole GV, Agnew SG, Griswold JA, Rhodes RS. The mangled lower extremity: Can salvage be predicted. American Surgeon. Jan 1994;60(1):50-55. [Medline].
Soto JA, Munera F, Morales C, et al. Focal arterial injuries of the proximal extremities: helical CT arteriography as the initial method of diagnosis. Radiology. Jan 2001;218(1):188-94. [Medline].
Soto JA, Múnera F, Cardoso N, Guarín O, Medina S. Diagnostic performance of helical CT angiography in trauma to large arteries of thhe extremities. J Comput Assist Tomogr. Mar-Apr 1999;23(2):188-96. [Medline].
Stain SC, Yellin AE, Weaver FA, Pentecost MJ. Selective management of nonocclusive arterial injuries. Arch Surg. Oct 1989;124(10):1136-40; discussion 1140-1. [Medline].
peripheral vascular injury, vascular trauma, tensile strain, shear strain, vessel rupture, intimal rupture, penetrating trauma, blunt trauma, stab wounds, gunshot wounds
Eric J Morley, MD, Resident, Department of Emergency Medicine, State University of New York Downstate/Kings County Hospital
Disclosure: Nothing to disclose.
Christopher I Doty, MD, FAAEM, Assistant Professor of Emergency Medicine, Combined EM/IM Residency Program Director, Department of Emergency Medicine, Kings County Hospital Center, State University of New York Downstate Medical Center
Christopher I Doty, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Peter MC DeBlieux, MD, Professor of Clinical Medicine and Pediatrics, Section of Pulmonary and Critical Care Medicine, Program Director, Department of Emergency Medicine, Louisiana State University Health Sciences Center
Peter MC DeBlieux, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Radiological Society of North America, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Eric Legome, MD, Residency Director, Assistant Professor of Emergency Medicine, Department of Emergency Medicine New York University, New York University Hospital, Bellevue Hospital Center, Manhattan VA
Eric Legome, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, Council of Emergency Medicine Residency Directors, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School
John Halamka, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors, A Antoine Kazzi, MD, Anupama Singh, MD, and Mazen El-Sayed, MD, to the development and writing of this article.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)